SCHEMBL22304641

SCHEMBL22304641

CC(C)(C)NCC1(CO)CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22147107 0.96
SCHEMBL17282113 0.91 LMNA (0.31)
SCHEMBL22147235 0.78
SCHEMBL12786572 0.75
SCHEMBL22304664 0.74
SCHEMBL20175247 0.73 SLC6A2 (0.30)
Hydrochloric Acid SCHEMBL26985619 0.73 SLC6A4 (0.31)
SCHEMBL17778081 0.71 PDCD1LG2 (0.34)
SCHEMBL17776631 0.71 KMT2A (0.32)
SCHEMBL16769524 0.71 ALDH1A1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210353630-A1 1,2,4-TRIAZIN-3(2H)-ONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES BAYER AKTIENGESELLSCHAFT (DE) 2021-11-18 US disclosed
WO-2020157201-A1 OXADIAZINONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES BAYER AKTIENGESELLSCHAFT (DE) 2020-08-06 WO disclosed